ANEW MEDICAL, INC. and REDWOOD ACQUISITION CORP. ANNOUNCE CLOSING OF THEIR BUSINESS COMBINATION

Provided By GlobeNewswire

Last update: Jun 21, 2024

ANEW MEDICAL, INC.’s shares and warrants are expected to begin trading on the Nasdaq Global Market under the tickers “WENA” and “WENAW”, respectively.

NEW YORK, NY, June 21, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or the “Company”), a biopharmaceutical technology company focused on developing disruptive new therapies to treat the central nervous system (“CNS”) and neurodegenerative diseases, and Redwoods Acquisition Corp. (NASDAQ: RWOD) (“RWOD”), a publicly-traded special purpose acquisition company, today announced the completion of their previously announced business combination (the “Business Combination”). The combined company will be named “ANEW MEDICAL, INC.” and its shares and warrants are expected to begin trading on the Nasdaq Global Market under the tickers “WENA”, and “WENAW”, respectively.